CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 434704-434902 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"The structure-based designed glycopeptide CSF114(Glc) is able to recognize specific auto-Abs in sera of an important subgroup (37%) of MS patients (250), but not in other autoimmune conditions (90).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T40941","span":{"begin":0,"end":198},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T40941","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T36","span":{"begin":0,"end":198},"obj":"Sentence"}],"attributes":[{"subj":"T36","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T860","span":{"begin":171,"end":192},"obj":"Phenotype"}],"attributes":[{"id":"A860","pred":"hp_id","subj":"T860","obj":"http://purl.obolibrary.org/obo/HP_0002960"},{"subj":"T860","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2963","span":{"begin":135,"end":137},"obj":"Disease"},{"id":"T99919","span":{"begin":135,"end":137},"obj":"Disease"}],"attributes":[{"id":"A2963","pred":"mondo_id","subj":"T2963","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A77720","pred":"mondo_id","subj":"T99919","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"subj":"T2963","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T99919","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#939cec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#b6ec93"},{"id":"CORD-19-PD-HP","color":"#ec93d0"},{"id":"CORD-19-PD-MONDO","color":"#93eaec"}]}]}}